Upsized facilities include a $300 million revolver and a $300 million delayed draw term loan, with lower pricing and expanded capacity to fund growth
2,702,180 shares of common stock, $0.0001 par value per share
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.